Literature DB >> 18500448

Behavior of neural stem cells in the Alzheimer brain.

B Waldau1, A K Shetty.   

Abstract

Alzheimer's disease (AD) is characterized by the deposition of beta-amyloid peptides (Abeta) and a progressive loss of neurons leading to dementia. Because hippocampal neurogenesis is linked to functions such as learning, memory and mood, there has been great interest in examining the effects of AD on hippocampal neurogenesis. This article reviews the pertinent studies and tries to unite them in one possible disease model. Early in the disease, oligomeric Abeta may transiently promote the generation of immature neurons from neural stem cells (NSCs). However, reduced concentrations of multiple neurotrophic factors and higher levels of fibroblast growth factor-2 seem to induce a developmental arrest of newly generated neurons. Furthermore, fibrillary Abeta and down-regulation of oligodendrocyte-lineage transcription factor-2 (OLIG2) may cause the death of these nonfunctional neurons. Therefore, altering the brain microenvironment for fostering apt maturation of graft-derived neurons may be critical for improving the efficacy of NSC transplantation therapy for AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500448      PMCID: PMC3612503          DOI: 10.1007/s00018-008-8053-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  108 in total

1.  Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease.

Authors:  T Bussière; P D Friend; N Sadeghi; B Wicinski; G I Lin; C Bouras; P Giannakopoulos; N K Robakis; J H Morrison; D P Perl; P R Hof
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

2.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

3.  Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus.

Authors:  Karin Boekhoorn; Marian Joels; Paul J Lucassen
Journal:  Neurobiol Dis       Date:  2006-06-30       Impact factor: 5.996

4.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

5.  Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

Authors:  Y M Kuo; M R Emmerling; C Vigo-Pelfrey; T C Kasunic; J B Kirkpatrick; G H Murdoch; M J Ball; A E Roher
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

6.  Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat.

Authors:  K Jin; M Minami; J Q Lan; X O Mao; S Batteur; R P Simon; D A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

7.  The window and mechanisms of major age-related decline in the production of new neurons within the dentate gyrus of the hippocampus.

Authors:  Muddanna S Rao; Bharathi Hattiangady; Ashok K Shetty
Journal:  Aging Cell       Date:  2006-12       Impact factor: 9.304

8.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

Authors:  J Murrell; M Farlow; B Ghetti; M D Benson
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

9.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.

Authors:  M P Mattson; B Cheng; D Davis; K Bryant; I Lieberburg; R E Rydel
Journal:  J Neurosci       Date:  1992-02       Impact factor: 6.167

10.  Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation.

Authors:  K M Felsenstein; L W Hunihan; S B Roberts
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

View more
  34 in total

1.  FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.

Authors:  Tomomi Kiyota; Kaitlin L Ingraham; Michael T Jacobsen; Huangui Xiong; Tsuneya Ikezu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

2.  Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.

Authors:  Da Yong Lee; Tu-Hsueh Yeh; Ryan J Emnett; Crystal R White; David H Gutmann
Journal:  Genes Dev       Date:  2010-09-28       Impact factor: 11.361

Review 3.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

4.  Decrease in Adult Neurogenesis and Neuroinflammation Are Involved in Spatial Memory Impairment in the Streptozotocin-Induced Model of Sporadic Alzheimer's Disease in Rats.

Authors:  Taysa Bervian Bassani; Jéssica M Bonato; Meira M F Machado; Valentín Cóppola-Segovia; Eric L R Moura; Silvio M Zanata; Rúbia M M W Oliveira; Maria A B F Vital
Journal:  Mol Neurobiol       Date:  2017-06-16       Impact factor: 5.590

5.  Stem cell transplantation for enhancement of learning and memory in adult neurocognitive disorders.

Authors:  Ben Waldau
Journal:  Aging Dis       Date:  2010-08-01       Impact factor: 6.745

Review 6.  Subventricular zone under the neuroinflammatory stress and Parkinson's disease.

Authors:  Keiji Mori; Yoko S Kaneko; Akira Nakashima; Hiroshi Nagasaki; Toshiharu Nagatsu; Ikuko Nagatsu; Akira Ota
Journal:  Cell Mol Neurobiol       Date:  2011-12-22       Impact factor: 5.046

Review 7.  Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.

Authors:  Raghavendra Upadhya; Winston Zingg; Siddhant Shetty; Ashok K Shetty
Journal:  J Control Release       Date:  2020-04-11       Impact factor: 9.776

8.  Cytotoxic effects of G(M1) ganglioside and amyloid β-peptide on mouse embryonic neural stem cells.

Authors:  Makoto Yanagisawa; Toshio Ariga; Robert K Yu
Journal:  ASN Neuro       Date:  2010-03-15       Impact factor: 4.146

9.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

10.  CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease.

Authors:  Tomomi Kiyota; Howard E Gendelman; Robert A Weir; E Elizabeth Higgins; Gang Zhang; Mohit Jain
Journal:  Neurobiol Aging       Date:  2012-10-04       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.